The Value of Contrast-Enhanced CT in the Detection of Residual Disease After Neo-Adjuvant Chemotherapy in Ovarian Cancer

To evaluate the diagnostic performance of contrast-enhanced computed tomography (CT) in predicting residual disease following neo-adjuvant chemotherapy (NACT) in stage III/IV ovarian cancer. This was a retrospective observational cohort study including consecutive patients with primary stage III/IV...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Academic radiology 2020-07, Vol.27 (7), p.951-957
Hauptverfasser:	An, He, Chiu, Keith W.H., Tse, K.Y., Ngan, Hextan Y.S., Khong, Pek-Lan, Lee, Elaine Y.P.
Format:	Artikel
Sprache:	eng
Schlagworte:	Contrast-enhanced CT Interval debulking surgery Neo-adjuvant chemotherapy Ovarian cancer
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!